Medication Scheduling for MDR-TB and Diabetes Management
Drug Interactions and Contraindications
The primary concern in this regimen is the interaction between ferrous sulfate and levofloxacin, which you have appropriately addressed by spacing them 8 hours apart. 1 Additionally, metformin requires careful monitoring given the patient's renal function and potential interactions with contrast procedures. 1
Key Interactions to Monitor:
- Iron and levofloxacin: Must remain at least 8 hours apart (already addressed) 2
- Metformin: Should be taken with meals to reduce gastrointestinal side effects and must be temporarily discontinued before any iodinated contrast procedures 1
- Potassium chloride: Must be taken with meals and a full glass of water to prevent gastrointestinal irritation 3
- No significant interactions exist between the TB medications (amikacin, linezolid, levofloxacin, cycloserine) and diabetes medications in this regimen 2
Recommended Daily Schedule
Morning (with breakfast):
- Gliclazide 80 mg - give 30 minutes before breakfast for optimal postprandial glucose control 4
- Metformin 500 mg - with food 1
- Levofloxacin 750-1000 mg - can be taken with or without food 2
- Linezolid 600 mg - can be taken with or without food 2
- Cycloserine (dose per guideline: 15-20 mg/kg/day) - with food 2
- Potassium chloride 750 mg - with full glass of water and food 3
Midday (with lunch):
- Metformin 500 mg - with food 1
Evening (with dinner):
- Potassium chloride 750 mg - with full glass of water and food 3
- Ferrous sulfate - at least 8 hours after morning levofloxacin dose 1
Amikacin Administration:
- Amikacin 15 mg/kg once daily - administer intravenously, preferably in the morning 2, 5, 6
- Once-daily dosing is preferred over multiple daily dosing for aminoglycosides, showing comparable efficacy with reduced nephrotoxicity risk 5, 7, 6
- Monitor trough levels only if creatinine clearance falls below 50 mL/min or renal function deteriorates 7
Regular Insulin:
- Administer subcutaneously before meals based on blood glucose readings 2
- Timing should be individualized based on glucose monitoring, typically 15-30 minutes before meals
- Avoid rapid- or short-acting insulin at bedtime 2
Critical Monitoring Points
Nephrotoxicity Risk:
- Duration of aminoglycoside treatment is the most significant risk factor for nephrotoxicity, not trough levels 7
- Monitor renal function regularly, especially with concurrent use of amikacin and other potentially nephrotoxic agents 2, 7
- Assess creatinine clearance before initiating and periodically during metformin therapy 1
Hypoglycemia Prevention:
- The combination of gliclazide, metformin, and insulin increases hypoglycemia risk 2, 4
- Monitor blood glucose before meals and adjust insulin accordingly 2
- Consider simplifying the insulin regimen if severe or recurrent hypoglycemia occurs 2
Gastrointestinal Tolerability:
- Potassium chloride tablets must not be crushed, chewed, or sucked - swallow whole with full glass of water 3
- If difficulty swallowing, break tablet in half or prepare aqueous suspension as directed in FDA labeling 3
- Metformin with meals reduces GI side effects 1
Special Precautions
Metformin Discontinuation Criteria:
- Stop metformin if eGFR falls below 30 mL/min/1.73 m² 1
- Discontinue before iodinated contrast procedures if eGFR is 30-60 mL/min/1.73 m², and restart only after confirming stable renal function 48 hours post-procedure 1
- Temporarily discontinue during acute illness that may compromise renal or liver function 2